IDEAYA Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $112.8M | $84.4M | $157.0M | $68.6M | $92.0M | $72.0M | $34.1M | $20.5M |
| Accounts Receivable | — | $3.0K | $18.0K | $211.0K | $1.1M | $1.9M | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $666.7M | $689.7M | $532.6M | $370.5M | $251.0M | $288.6M | $101.7M | $90.7M |
| Property, Plant & Equipment | $8.2M | $9.0M | $6.2M | $6.5M | $4.8M | $4.3M | $4.6M | $5.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $1.11B | $1.12B | $649.3M | $388.0M | $381.3M | $298.3M | $113.0M | $96.5M |
| Liabilities | ||||||||
| Accounts Payable | $17.6M | $15.4M | $6.6M | $4.3M | $2.1M | $953.0K | $709.0K | $1.4M |
| Total Current Liabilities | $58.8M | $46.1M | $27.1M | $31.7M | $45.2M | $38.6M | $6.9M | $5.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $86.4M | $64.9M | $28.2M | $38.5M | $79.8M | $100.0M | $12.6M | $7.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-736.5M | $-622.8M | $-348.4M | $-235.4M | $-176.7M | $-127.0M | $-92.5M | $-50.5M |
| Total Stockholders' Equity | $1.02B | $1.06B | $621.1M | $349.5M | $301.5M | $198.3M | $100.4M | $-48.9M |